The purpose of evaluating prognostic factors in acute lymphoblastic leukemia is, first, to stratify patients into adverse- or good-risk groups, second, to determine different treatment options accordingly and, third, to evaluate their potential outcome. Prognostic factors are particularly relevant for disease-free survival and overall survival.
Keywords: acute lymphoblastic leukemia; minimal residual disease; prognostic factors; risk stratification; targeted therapies.